Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

R. Dummer, D. Schadendorf, A. Hauschild, M. Santinami, V. G. Atkinson, M. Mandala, V. Chiarion Sileni, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, X. Feng, E. de Jong, B. Mookerjee, R. Kefford, J. M. Kirkwood, G. V. Long

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
Original languageEnglish
Article number1250P
Pages (from-to)viii445
Number of pages1
JournalAnnals of Oncology
Volume29
Issue numberSupplement 8
DOIs
Publication statusPublished - 1 Oct 2018
Event43rd European Society for Medical Oncology Congress (ESMO 2018) - Munich, Germany
Duration: 19 Oct 201823 Oct 2018

Cite this